Whereas anti–PD-1 markedly suppressed tumor growth in only 4 of 10 mice, strikingly, the combination of XmAb808 and anti–PD-1 suppressed tumor growth in all treated mice (Fig. 6A and B). Here, PDCD1 is linked to neoplasm.